- Hairy cell leukaemia therapy (HCL) with interferon alpha1994 | First Faculty of Medicine
- Dasatinib as first line therapy in chronic myeloid leukaemia2011 | Faculty of Medicine in Hradec Králové
- Modified cyclopentadienyl molybdenum compounds with enhanced cytotoxic activity towards MOLT-4 leukaemia cells2017 | Faculty of Medicine in Hradec Králové
- Inhibition of AKR1B10-mediated metabolism of daunorubicin as a novel off-target effect for the Bcr-Abl tyrosine kinase inhibitor dasatinib2021 | Faculty of Pharmacy in Hradec Králové